SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

Aveanna Healthcare Holdings Inc. (AVAH) News

Follow Aveanna Healthcare Holdings Inc. (AVAH) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 16 public stories across 10 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol AVAH Asset equity Sector Markets 90 days 9 Last 11.005 Updated Nov 12, 2026, 12:36 PM UTC Open live news feed Open AVAH chart & news
M Aveanna Healthcare Raises 2026 Revenue Guidance as Q3 Earnings and Revenue Rise EQUITY | Nov 12, 2026, 12:36 PM UTC M Aveanna Q3 Revenue Rises 11.8%; 2026 Guidance Raised Q3 revenue was $695.5 million versus $621.9 million a year earlier, while net income was $45.5 million versus $14.1 million. Adjusted EBITDA rose 25.0% to $100.1 million; Aveanna raised its 2026 revenue and Adjusted EBIT EQUITY | Nov 12, 2026, 12:16 PM UTC L Top 3 Health Care Stocks That Are Ticking Portfolio Bombs As of Sept. 10, 2026, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indicator, which compares EARNINGS | Sep 10, 2026, 12:25 PM UTC L Aveanna Healthcare maintained at Overweight by Barclays Barclays maintained Aveanna Healthcare at Overweight, according to TradingView News. EQUITY | Aug 28, 2026, 02:57 PM UTC L Healthcare Exec Lists $18.25 Million French Chateau-Style Home Outside Atlanta — WSJ Healthcare Exec Lists $18.25 Million French Chateau-Style Home Outside Atlanta — WSJ EQUITY | Aug 27, 2026, 01:18 PM UTC L Aveanna to Participate in Deutsche Bank 2026 Healthcare Summit Aveanna said it will participate in the Deutsche Bank 2026 Healthcare Summit. EQUITY | Aug 27, 2026, 11:07 AM UTC L AVAH - Aveanna to Participate in the Deutsche Bank 2026 Healthcare Summit AVAH - Aveanna to Participate in the Deutsche Bank 2026 Healthcare Summit EQUITY | Aug 27, 2026, 11:00 AM UTC L Aveanna (AVAH) to Participate in 2026 Jefferies Healthcare Conference Aveanna says it will participate in the 2026 Jefferies Healthcare Services and Technology Conference. EQUITY | Aug 25, 2026, 11:00 AM UTC L RBC reiterates Outperform on AVAH, raises price target to $16 RBC reiterates Outperform on AVAH and raises its price target to $16 from $10. EQUITY | Aug 24, 2026, 11:29 AM UTC L RCL completes $1.25 billion senior unsecured notes offering RCL completes its offering of $1.25 billion senior unsecured notes due 2034; the wire also lists secondary-stock offering and registration items for AVAH, BKV, NCEL and PYXS. RATES | Aug 21, 2026, 10:59 AM UTC M AVAH shares fall premarket after offering priced at $11.75 AVAH shares trade -8.9% premarket following a stock offering priced at $11.75, according to Hammerstone MarketTalk. EQUITY | Aug 21, 2026, 10:43 AM UTC M Aveanna Healthcare prices secondary offering of 15M shares at $11.75 Aveanna Healthcare (AVAH) announces the pricing of a secondary offering of 15M shares at $11.75 per share. EQUITY | Aug 21, 2026, 10:42 AM UTC L Aveanna prices secondary offering of common stock Aveanna (AVAH) announces pricing of a secondary offering of common stock; no catalyst or transaction size was supplied in the alert. MNA | Aug 21, 2026, 12:16 AM UTC L Aveanna launches secondary offering of common stock Aveanna Health announces the launch of a secondary offering of common stock, with no price, size or use-of-proceeds details supplied in the alert. MNA | Aug 20, 2026, 08:09 PM UTC L Aveanna Healthcare Holdings reports Q2 results; revises 2026 guidance Aveanna Healthcare Holdings (AVAH) announces second-quarter financial results and revised 2026 guidance, according to TradeXchange Newsdesk, without any further figures or rationale provided in the feed. EARNINGS | Aug 13, 2026, 11:01 AM UTC H Aveanna price target raised to $9.50 from $9 at Barclays Barclays raised the firm's price target on Aveanna to $9.50 from $9 and keeps an Overweight rating on the shares. The firm adjusted targets among its U.S. healthcare facilities and managed care coverage ahead of Q2 earni EQUITY | Jul 08, 2026, 10:20 AM UTC